同時併存之攝護腺癌及泌尿道癌之探討: 彰化基督教醫院經驗報告
方楚文、王百孚、林介山、江恆杰、張進寶、嚴孟意、黃勝賢、陳俊吉、石宏仁、張建祥
彰化基督教醫院外科部泌尿外科
The prevalence and risk factors for synchronous prostate carcinoma and urothelial carcinoma: experience in cch
Chu-Wen Fang, Bai-Fu Wang, Jie-Shan Lin, Heng-Jie Jiang, Jin-Bao Zhang, Mon-I Yen, Sheng-Xian Huang, Jun-Ji Chen, Hong-ren Shi, Jian-Xiang Zhang
Division of Urology, Department of Surgery, Changhua Christian Hospital, Taiwan
Purpose:
There were few reports regarding synchronous and simultaneous occurrence of prostate carcinoma and urothelial carcinoma. We were interested in this issue and perform the study for prevalence rate and risk factors in synchronous prostate carcinoma and urothelial carcinoma.
Materials and Methods:
In this retrospective study between 2013~2015, patients admitted to Changhua Christian Hospital with diagnosed synchronous prostate carcinoma and urothelial carcinoma were included and carefully reviewed. The final diagnosis of double cancer was identified by pathologic reports. The demographics and characteristics of patients or comorbidity were studied, as well as the prevalence rate of comorbidities and risk factors.
Results:
A preliminary collection of 31 male patients were enrolled, and the mean age is 81.7 +- 7.9 y/o. There were 35.5% patients noted with hypertension, with diabetes in the second place (22.6%), coronary artery disease and gout in the third place (19.4%), followed by lithiasis (12.9 %) and autoimmune disorder (12.9%). Most of the patients were more than 80 year-old.
Conclusion:
Results of our study show that hypertension, diabetes, as well as gout were associated with prevalence of synchronous prostate carcinoma and urothelial carcinoma. However, further studies were needed.